The Feasibility and Outcome of Intravenous Thrombolysis for Stroke Patients in the 3-4.5 Hour Time Window in China
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Plasminogen activator enzymes (Primary) ; Thrombolytics
- Indications Embolism and thrombosis; Stroke
- Focus Therapeutic Use
- 10 Dec 2014 Biomarkers information updated
- 01 Apr 2013 Planned number of patients changed from 100 to 200 as reported by ClinicalTrials.gov.
- 01 Apr 2013 Planned End Date changed from 31 Jan 2013 to 1 Apr 2013 as reported by ClinicalTrials.gov.